Elevance Health (ELV)

Elevance Health (ELV) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

Elevance Bounces as Insurer Pressure Persists

Elevance rose 2.0% today while the Nasdaq 100 fell 0.7%, but shares remain down 7.4% over the past week. Investors are weighing the health-insurer sector’s recent weakness against the company’s reaffirmed 2026 earnings guidance and its next report in January.

Published 2026-11-20 15:01:49 UTC.